IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE.
Wiad Lek. 2021;74(1):11-16.
The aim: Of this study was to improve the efficiency of complex medicamental treatment of generalized periodontitis (GP) in patients with concomitant CAD using of differentiated immunotropic therapy, especially herbal medicine «Immuno-ton».
Material and methods: 130 patients with GP were observed (43 without and 81 with chronic CAD - stable angina, functional classes II-III (CCS)) with detection of oral hygiene indices for Green-Vermillion, inflammation of gums PMA, bleeding of gums PBI, depth of periodontal pockets (determined by direct method). The levels of TNF-α and sPECAM-1 in gingival fluid were detected by ELISA method.
Results: The following article is dedicated to studying on the effectiveness of the proposed method of GP I and II degree of development treatment in patients with a concomitant coronary artery disease (CAD) using of herbal medicines with immunomodulating effect. The offered methods provide disappearance of clinical signs of inflammation in the periodontal tissues and prevention of inflammation recurrence in the long terms. Also, it was proved that usage of the forward method of the GP immunotropic therapy with including of herbal immunomodulators leads to normalization of dynamics of tumor necrosis factor -alfa (TNF-α) and soluble platelet-endothelial cell adhesion molecule -1 (sPECAM-1) in oral fluid of abovementioned contingent of patients.
Conclusions: The progression of generalized periodontitis in patients with stable coronary heart disease is accompanied with manifestation of systemic inflammation, which have been reduced by immunomodulator Immuno-Ton and extratemporal gel with "Enterosgel" and herbal concentrate "Dzherelo".
本研究旨在通过使用免疫调节治疗,特别是草药“免疫酮”,提高伴有合并 CAD 的广泛性牙周炎(GP)患者的复杂药物治疗效率。
材料和方法:观察了 130 名 GP 患者(43 名无慢性 CAD,81 名稳定型心绞痛,功能等级 II-III(CCS)),检测了绿-维美伦口腔卫生指数、牙龈 PMA 炎症、牙龈 PBI 出血、牙周袋深度(直接法测定)。通过 ELISA 法检测龈液中 TNF-α 和 sPECAM-1 的水平。
本文致力于研究在伴有冠状动脉疾病(CAD)的患者中,使用具有免疫调节作用的草药治疗 II 度和 II 度发展的 GP 的有效性。所提供的方法可消除牙周组织的临床炎症迹象,并长期预防炎症复发。此外,还证明了使用包括草药免疫调节剂在内的 GP 免疫疗法的前进方法,可使上述患者群体的肿瘤坏死因子-α(TNF-α)和可溶性血小板内皮细胞黏附分子-1(sPECAM-1)的动态正常化。
稳定型冠心病患者的广泛性牙周炎进展伴随着全身炎症的表现,这种炎症已经通过免疫调节剂“免疫酮”和“Enterosgel”的外时凝胶以及草药浓缩物“Dzherelo”得到了减轻。